(Q41968982)

14 October 2017

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis (English)

1 reference

Mycobacterium tuberculosis

14 October 2017

0 references

author name string

Kristian Ängeby

1

1 reference

14 October 2017

Pontus Juréen

2

1 reference

14 October 2017

Gunnar Kahlmeter

3

1 reference

14 October 2017

Sven E Hoffner

4

1 reference

14 October 2017

Thomas Schön

5

1 reference

14 October 2017

language of work or name

English

0 references

publication date

29 May 2012

1 reference

14 October 2017

6

1 reference

Bulletin of the World Health Organization

inferred from page(s)

published in

1 reference

14 October 2017

90

1 reference

14 October 2017

693-698

1 reference

14 October 2017

9

1 reference

Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing

14 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442398

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442398

Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442398

Breakpoints for susceptibility testing should not divide wild-type distributions of important target species

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442398

Drug-susceptibility testing in tuberculosis: methods and reliability of results

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442398

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442398

Antimicrobial susceptibility in Escherichia coli of human and avian origin--a comparison of wild-type distributions

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442398

Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3442398

European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22984314

12 December 2020

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/22984314

12 December 2020

inferred from PubMed ID database lookup

Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22984314

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.2471/BLT.11.096644

1 reference

14 October 2017

1 reference

14 October 2017

1 reference